New cancer drug enters human testing for Tough-to-Treat tumors
NCT ID NCT06170190
Summary
This was an early-stage study to test a new cancer drug called IBI133 for the first time in people. It involved 19 adults with advanced solid tumors that could not be removed by surgery and had stopped responding to standard treatments. The main goals were to find a safe dose and see how the body processes the drug, while also getting an early look at whether it might help control the cancer.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LOCALLY ADVANCED UNRESECTABLE OR METASTATIC SOLID TUMORS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Liverpool Hospital
Liverpool, New South Wales, 2170, Australia
Conditions
Explore the condition pages connected to this study.